West Pharmaceutical Services Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 70 trades in West Pharmaceutical Services Inc (NYSE: WST) since 2014, across 12 members, worth an estimated $691.03K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 41 buys against 29 sells, a modestly buy-led skew, with Democratic members responsible for 73% of the trades and Republican members 27%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most WST transactions among those shown, with 4. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, up 49.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. West Pharmaceutical Services Inc's current Quantellect Tide Score is 65 out of 100 (High Tide), Top 24% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the West Pharmaceutical Services Inc (WST) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
West Pharmaceutical Services congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | SELL |  $1,001 - $15,000 | +11.63% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 27, 2026 | 13 days | SELL | $1,001 - $15,000 | +11.44% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | +50.57% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | BUY | $1,001 - $15,000 | +49.90% | Spouse |
West Pharmaceutical Services (WST) congressional trading FAQ
Can members of Congress legally trade West Pharmaceutical Services (WST) stock?
Yes. Members of Congress are permitted to trade individual stocks, including West Pharmaceutical Services (WST), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional West Pharmaceutical Services (WST) trades public?
Yes. Every congressional trade in West Pharmaceutical Services (WST) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded West Pharmaceutical Services (WST)?
Members of Congress have disclosed 70 trades in West Pharmaceutical Services (WST) worth $691.03K across 12 members, according to public STOCK Act filings.
Which members of Congress have traded West Pharmaceutical Services (WST)?
Recent and active filers of West Pharmaceutical Services (WST) disclosures include Rohit Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade West Pharmaceutical Services (WST) more?
Across disclosed West Pharmaceutical Services (WST) trades, 73% were by Democrats and 27% by Republicans, led by Democrats (73%).
What is the most recent congressional West Pharmaceutical Services (WST) trade?
The most recent disclosed West Pharmaceutical Services (WST) trade was a sale by Rohit Khanna, filed Jul 5, 2026.
What is West Pharmaceutical Services (WST)'s Tide Score?
West Pharmaceutical Services (WST) has a Quantellect Tide Score of 65 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewWest Pharmaceutical Services (WST) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.